maintenance after tirzepatide What are the doses of (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) for a patient who has reached their goal weight? Presented today at #ECO2026 ⤵️

Do roasted almonds and pecans lose nutrients

3/5/26 Update: Wegovy Pill A new oral version of Wegovy (semaglutide) is now becoming available, offering patients a daily pill alternative to the weekly injection

Despite robust clinical evidence, barriers such as high costs, limited access, lack of awareness of approved indications, and practitioner hesitancy continue to impede widespread adoption

Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future

Treatments can be performed on the buttocks, abdomen, arms, and thighs

Manufactured in a facility that processes milk, soy, egg proteins, gluten, peanuts